| Pharmaceuticals from development to practice: learnings from an online curriculum. | |
| | |
MedLine Citation:
|
PMID: 19954269 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To report outcomes of a pilot online curriculum educating clinicians about off-label prescribing, finding unbiased sources of pharmaceutical information, and responding to patient inquiries about direct-to-consumer advertised medications. STUDY DESIGN: Case study. METHODS: We developed 3 case-oriented Internet modules to educate healthcare professionals about off-label prescribing, accessing and appraising unbiased drug information, and talking with patients about direct-to-consumer advertising. Modules included reflective questions and opportunities to asynchronously ask questions of faculty. Pilot testing occurred among 52 Kaiser Permanente Colorado prescribing clinicians from May 2007 through September 2007. We assessed self-reported changes in knowledge, intent-to-change practice, and barriers to practice change. We also examined curriculum participant pre-post changes in prescribing of selected highly advertised medications. RESULTS: Most participants reported changes in knowledge after curriculum completion, many made intent-to-change practice statements at curriculum completion, and several reported changes in practice 3 to 6 months after curriculum completion. Six categories of barriers to practice change were noted. Prescribing of targeted medications rose by 0.8 prescription per month in the intervention group and by 6.3 prescriptions per month in the control group, but this difference was not significant (P = .17). CONCLUSIONS: Targeted curricula on aspects of the pharmaceutical development, approval, and marketing process can lead to subjective changes in clinician knowledge and can facilitate intent-to-change practice. Larger studies are needed to assess the effect of such interventions on prescribing patterns. |
| | |
Authors:
|
David W Price; Marsha A Raebel; Douglas A Conner; Leslie A Wright; Nikki M Carroll |
Related Documents
:
|
18086259 - How dialysis is paid for: what the dialysis medical director should know, and why. 8192299 - Diffusion, dissemination, and implementation: who should do what? 21049779 - Medication reconciliation: another change planned. 2341689 - Comprehensive assessment of aids patients using the behavioural systems model for nursi... 2899849 - Somatostatin-28 effects on central nervous system regulation of vasopressin secretion a... 11900569 - Pathologists in a teaching institution assess the value of the autopsy. 2963549 - Pit and fissure sealant use in private practice: influence of state practice acts. 2244079 - Statistics for medical students in the 1990's: how should we approach the future? 11703639 - Adaptive and maladaptive perfectionism in medical students: a longitudinal investigation. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-12-01 |
Journal Detail:
|
Title: The American journal of managed care Volume: 15 ISSN: 1936-2692 ISO Abbreviation: Am J Manag Care Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-12-03 Completed Date: 2010-03-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9613960 Medline TA: Am J Manag Care Country: United States |
Other Details:
|
Languages: eng Pagination: e109-14 Citation Subset: H |
Affiliation:
|
Kaiser Permanente Institute for Health Research, 10065 E Harvard Ave, Ste 300, Denver, CO 80231, USA. david.price@kp.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Colorado Curriculum* Drug Approval* Health Knowledge, Attitudes, Practice Internet* Off-Label Use Pilot Projects Prescription Drugs / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Prescription Drugs |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An exploratory comparison of medication lists at hospital admission with administrative database rec...
Next Document: A physician-friendly alternative to prior authorization for prescription drugs.